Fannin Innovation Studio
Fannin Innovation Studio is an early-stage life science development group based in Houston, Texas. It focuses on commercializing innovations from Texas Medical Center institutions by providing startups with office space, seed capital, and a network of resources. The company aims to bridge Houston's commercialization gap through an apprenticeship program that trains aspiring entrepreneurs.
Top Regions
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Houston, TX
Procyrion
Series E in 2024
Procyrion is a clinical-stage medical device company that designs and manufactures catheter-based circulatory support devices, most notably the Aortix heart pump. The percutaneous device is implanted via the leg through a catheter between the heart and kidneys to unload the failing heart, improve perfusion to vital organs, and rest the heart to aid recovery in patients with heart failure who are not responding to medications. It aims to decongest acute decompensated heart failure and reduce afterload while preserving kidney perfusion, enabling treatment of patients who are too sick for conventional therapies. Founded in 2005 and based in Houston, Texas.
Procyrion
Series D in 2019
Procyrion is a clinical-stage medical device company that designs and manufactures catheter-based circulatory support devices, most notably the Aortix heart pump. The percutaneous device is implanted via the leg through a catheter between the heart and kidneys to unload the failing heart, improve perfusion to vital organs, and rest the heart to aid recovery in patients with heart failure who are not responding to medications. It aims to decongest acute decompensated heart failure and reduce afterload while preserving kidney perfusion, enabling treatment of patients who are too sick for conventional therapies. Founded in 2005 and based in Houston, Texas.
Procyrion
Series B in 2015
Procyrion is a clinical-stage medical device company that designs and manufactures catheter-based circulatory support devices, most notably the Aortix heart pump. The percutaneous device is implanted via the leg through a catheter between the heart and kidneys to unload the failing heart, improve perfusion to vital organs, and rest the heart to aid recovery in patients with heart failure who are not responding to medications. It aims to decongest acute decompensated heart failure and reduce afterload while preserving kidney perfusion, enabling treatment of patients who are too sick for conventional therapies. Founded in 2005 and based in Houston, Texas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.